L-asparaginase Encapsulated in Red Blood Cells (Eryaspase) for Treatment of Adult Patients With ALL or LBL
Clinical trial NCT01910428 · TERMINATED
Trial details
- NCT number
- NCT01910428
- Sponsor
- ERYtech Pharma
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2018-01-25
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.